Patton Albertson Miller Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.27M | Sell |
12,507
-56
| -0.4% | -$26.9K | 0.62% | 47 |
|
|
2026
Q1 | $6.18M | Buy |
12,563
+342
| +3% | +$186K | 0.73% | 42 |
|
|
2025
Q4 | $7.08M | Buy |
12,221
+54
| +0.4% | +$30.5K | 0.83% | 34 |
|
|
2025
Q3 | $5.9M | Buy |
12,167
+45
| +0.4% | +$20.9K | 0.71% | 42 |
|
|
2025
Q2 | $4.91M | Buy |
12,122
+1,164
| +11% | +$487K | 0.65% | 51 |
|
|
2025
Q1 | $5.45M | Sell |
10,958
-3,488
| -24% | -$1.89M | 0.81% | 43 |
|
|
2024
Q4 | $7.52M | Buy |
14,446
+500
| +4% | +$275K | 1.01% | 33 |
|
|
2024
Q3 | $8.63M | Sell |
13,946
-479
| -3% | -$284K | 1.17% | 23 |
|
|
2024
Q2 | $7.98M | Buy |
14,425
+904
| +7% | +$518K | 1.13% | 23 |
|
|
2024
Q1 | $7.86M | Buy |
13,521
+952
| +8% | +$534K | 1.18% | 24 |
|
|
2023
Q4 | $6.67M | Buy |
12,569
+1,544
| +14% | +$747K | 1.11% | 25 |
|
|
2023
Q3 | $5.58M | Buy |
11,025
+78
| +0.7% | +$41.6K | 1.09% | 27 |
|
|
2023
Q2 | $5.71M | Sell |
10,947
-80
| -0.7% | -$43.2K | 1.1% | 23 |
|
|
2023
Q1 | $6.36M | Buy |
11,027
+149
| +1% | +$84K | 1.16% | 19 |
|
|
2022
Q4 | $5.99M | Sell |
10,878
-190
| -2% | -$101K | 1.1% | 20 |
|
|
2022
Q3 | $5.61M | Buy |
11,068
+222
| +2% | +$124K | 1.21% | 19 |
|
|
2022
Q2 | $5.89M | Sell |
10,846
-75
| -0.7% | -$41.3K | 1.2% | 15 |
|
|
2022
Q1 | $6.45M | Sell |
10,921
-40
| -0.4% | -$23K | 1.11% | 19 |
|
|
2021
Q4 | $7.31M | Buy |
10,961
+566
| +5% | +$353K | 1.18% | 17 |
|
|
2021
Q3 | $5.94M | Buy |
10,395
+2,748
| +36% | +$1.51M | 1.14% | 16 |
|
|
2021
Q2 | $3.86M | Buy |
7,647
+137
| +2% | +$64.6K | 0.88% | 32 |
|
|
2021
Q1 | $3.43M | Buy |
7,510
+22
| +0.3% | +$10.5K | 0.83% | 35 |
|
|
2020
Q4 | $3.75M | Sell |
7,488
-43
| -0.6% | -$20.2K | 0.89% | 27 |
|
|
2020
Q3 | $3.33M | Sell |
7,531
-380
| -5% | -$157K | 0.94% | 27 |
|
|
2020
Q2 | $2.87M | Sell |
7,911
-112
| -1% | -$37.5K | 0.83% | 32 |
|
|
2020
Q1 | $2.27M | Sell |
8,023
-173
| -2% | -$54.6K | 0.77% | 36 |
|
|
2019
Q4 | $2.66M | Buy |
8,196
+281
| +4% | +$85.2K | 0.7% | 40 |
|
|
2019
Q3 | $2.31M | Sell |
7,915
-106
| -1% | -$30.4K | 0.65% | 47 |
|
|
2019
Q2 | $2.22M | Buy |
8,021
+449
| +6% | +$124K | 0.64% | 52 |
|
|
2019
Q1 | $2.07M | Buy |
7,572
+94
| +1% | +$23.4K | 1.05% | 30 |
|
|
2018
Q4 | $1.83M | Sell |
7,478
-353
| -5% | -$82.8K | 0.98% | 26 |
|
|
2018
Q3 | $1.73M | Sell |
7,831
-264
| -3% | -$60.7K | 0.88% | 31 |
|
|
2018
Q2 | $1.68M | Sell |
8,095
-144
| -2% | -$30.6K | 0.85% | 38 |
|
|
2018
Q1 | $1.7M | Sell |
8,239
-70
| -0.8% | -$14.7K | 0.76% | 40 |
|
|
2017
Q4 | $1.58M | Buy |
8,309
+32
| +0.4% | +$6.13K | 0.64% | 49 |
|
|
2017
Q3 | $1.6M | Buy |
8,277
+729
| +10% | +$132K | 0.7% | 44 |
|
|
2017
Q2 | $1.32M | Sell |
7,548
-771
| -9% | -$130K | 0.59% | 57 |
|
|
2017
Q1 | $1.43M | Buy |
8,319
+449
| +6% | +$68.6K | 0.59% | 53 |
|
|
2016
Q4 | $1.11M | Sell |
7,870
-280
| -3% | -$41.3K | 0.47% | 66 |
|
|
2016
Q3 | $1.3M | Sell |
8,150
-1,212
| -13% | -$187K | 0.57% | 53 |
|
|
2016
Q2 | $1.38M | Sell |
9,362
-1,642
| -15% | -$242K | 0.62% | 46 |
|
|
2016
Q1 | $1.56M | Sell |
11,004
-149
| -1% | -$20K | 0.79% | 43 |
|
|
2015
Q4 | $1.58M | Sell |
11,153
-102
| -0.9% | -$13.6K | 0.8% | 45 |
|
|
2015
Q3 | $1.37M | Sell |
11,255
-752
| -6% | -$98K | 0.73% | 56 |
|
|
2015
Q2 | $1.56M | Buy |
12,007
+1,214
| +11% | +$158K | 0.68% | 67 |
|
|
2015
Q1 | $1.45M | Buy |
10,793
+3,926
| +57% | +$506K | 0.59% | 71 |
|
|
2014
Q4 | $860K | Buy |
6,867
+1,808
| +36% | +$220K | 0.4% | 88 |
|
|
2014
Q3 | $614K | Buy |
5,059
+2,295
| +83% | +$279K | 0.32% | 99 |
|
|
2014
Q2 | $327K | Buy |
2,764
+721
| +35% | +$84.9K | 0.17% | 136 |
|
|
2014
Q1 | $246K | Buy |
+2,043
| New | +$243K | 0.13% | 151 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
Patton Albertson Miller Group's TMO Position: Q2 2026 in Review
Patton Albertson Miller Group reduced its Thermo Fisher Scientific (TMO) stake by 0.45% in Q2 2026, selling an estimated $26.9K and leaving 12,507 shares worth $6.27M. The position accounts for 0.62% of the portfolio, ranked #47.
Patton Albertson Miller Group first reported a position in TMO in Q1 2014 and has held it in 50 quarters since. The position peaked at $8.63M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Patton Albertson Miller Group held 12,507 shares of Thermo Fisher Scientific worth $6.27M as of Q2 2026.
- Patton Albertson Miller Group sold 56 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.9K.
- Thermo Fisher Scientific made up 0.62% of Patton Albertson Miller Group's portfolio in Q2 2026, its #47 holding.
- Patton Albertson Miller Group first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 50 quarters since.
- Patton Albertson Miller Group's Thermo Fisher Scientific position peaked at $8.63M in Q3 2024.
- 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.